Patents by Inventor Sudhanand Prasad
Sudhanand Prasad has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11739082Abstract: The present invention relates to novel thiophene compounds of general Formula I, and their stereoisomers (diastereoisomers, enantiomers), pure or mixed, racemic mixtures, geometrical isomers, tautomers, pharmaceutically acceptable salts, hydrates, solvates, solid forms and mixtures thereof along with process for their preparation. The present invention discloses compounds that are useful in the treatment and prevention of autoimmune diseases.Type: GrantFiled: August 31, 2018Date of Patent: August 29, 2023Assignee: Ahammune Biosciences Private LimitedInventors: Kashinath Komirishetty, Mahesh Kumar Verma, Parul Ganju, Sudhanand Prasad
-
Publication number: 20210380538Abstract: The present invention relates to novel pharmaceutical agents and the process of preparation thereof. The present invention discloses compounds of general formula I, and the process of their preparation. The compounds of the invention are useful in the treatment and prevention of diseases related to cellular stress mediated immune deregulation and loss of homeostasis also including autoimmune diseases, cancers, metabolic, dermatological, cardiovascular and neurodegenerative diseases.Type: ApplicationFiled: November 1, 2019Publication date: December 9, 2021Inventors: Mahesh Kumar VERMA, Kashinath KOMIRISHETTY, Parul GANJU, Sudhanand PRASAD, Annie RICHHARIA, Sanket Sanjay SHETE
-
Publication number: 20210275502Abstract: The present invention relates to a process for preparing N-[2-[2-(4-chlorophenyl)-4-thiazolyl] ethyl]-butanamide. The present invention further relates to a pharmaceutical formulation and the use of said pharmaceutical formulation consisting of N-[2-[2-(4-chlorophenyl) -4-thiazolyl]ethyl]-butanamide or pharmaceutically acceptable salts thereof as active compound for the treatment and prevention of autoimmune diseases and diseases involving skin immunology, skin autoimmune diseases and pigmentation disorders.Type: ApplicationFiled: April 26, 2019Publication date: September 9, 2021Inventors: Parul GANJU, Sudhanand PRASAD, Mahesh Kumar VERMA, Kashinath KOMIRISHETTY, Annie RICHHARIA
-
Publication number: 20200255417Abstract: The present invention relates to novel thiophene compounds of general Formula I, and their stereoisomers tures, geometrical isomers, tautomers, pharmaceutically acceptable salts, hydrates, solvates, solid forms and mixtures thereof along with process for their preparation. The present invention discloses compounds that are useful in the treatment and prevention of autoimmune diseases.Type: ApplicationFiled: August 31, 2018Publication date: August 13, 2020Applicant: AHAMMUNE BIOSCIENCES PRIVATE LIMITEDInventors: Kashinath KOMIRISHETTY, Mahesh Kumar VERMA, Parul GANJU, Sudhanand PRASAD
-
Patent number: 10232047Abstract: The present invention is directed to anti-fungal compositions comprising an anti-fungal agent, an oil and excipients or additives. The compositions of the present invention are devoid of C-11 or greater fatty acids/esters.Type: GrantFiled: December 20, 2012Date of Patent: March 19, 2019Assignee: VYOME BIOSCIENCES PRIVATE LIMITEDInventors: Sudhanand Prasad, Nilu Jain, Sumana Ghosh, Suresh Chawrai
-
Publication number: 20180214472Abstract: The invention provides conjugate-based antifungal or antibacterial prodrugs formed by coupling at least one antifungal agent or antibacterial agent with at least one linker and/or carrier. The prodrugs are of formula: (i) (AFA)m-X-(L)n; (ii) [(AFA)m?-X]p-L; (iii) AFA-[X-(L)n?]q; or (iv) (AFA)m?-X, wherein: AFA is an antifungal agent or an antibacterial agent; L is a carrier; X is a linker; m ranges from 1 to 10; n ranges from 2 to 10; m? is 1 to 10; p is 1 to 10; n? is 1 to 10; and q is 1 to 10, provided that q? and n are not both 1; and m? is 1 to 10. The invention also provides nonaparticles comprising the conjugate-based prodrugs. Additionally, the invention also provides non-conjugated antifungal and antibacterial agents in the form of nanoparticles.Type: ApplicationFiled: January 23, 2018Publication date: August 2, 2018Applicant: VYOME BIOSCIENCES, PVT. LTD.Inventors: Abhijit S. Bapat, Gauthami Mahesh, Rajesh S. Gokhale, Sayali S. Shah, Shiladitya Sengupta, Sudhanand Prasad, Sumana Ghosh, Suresh R. Chawrai, Nidhi Arora, D. Sreedhar Reddy, Mallika Mishra, Kirti Bajaj
-
Patent number: 9907812Abstract: The invention provides conjugate-based antifungal or antibacterial prodrugs formed by coupling at least one anti-fungal agent or antibacterial agent with at least one linker and/or carrier. The prodrugs are of formula: (i) (AFA)m-X-(L)n; (ii) [(AFA)m?-X]p-L; (iii) AFA-[X-(L)n?]q; or (iv) (AFA)m?-X, wherein: AFA is an antifungal agent or an antibacterial agent; L is a carrier; X is a linker; m ranges from 1 to 10; n ranges from 2 to 10; m? is 1 to 10; p is 1 to 10; n? is 1 to 10; and q is 1 to 10, provided that q? and n are not both 1; and m? is 1 to 10. The invention also provides nanoparticles comprising the conjugate-based prodrugs. Additionally, the invention also provides non-conjugated antifungal and antibacterial agents in the form of nanoparticles.Type: GrantFiled: June 22, 2012Date of Patent: March 6, 2018Assignee: VYOME BIOSCIENCES PVT. LTD.Inventors: Abhijit S. Bapat, Gauthami Mahesh, Rajesh S. Gokhale, Sayali S. Shah, Shiladitya Sengupta, Sudhanand Prasad, Sumana Ghosh, Suresh R. Chawrai, Nidhi Arora, D. Sreedhar Reddy, Mallika Mishra, Kirti Bajaj
-
Publication number: 20160128944Abstract: The invention provides species of lipid, protein, and/or cationic molecule coated active agents and compositions comprising the coated particles. The compositions can be personal care compositions such as anti-dandruff shampoo or conditioner, skin care compositions, creams, gels, toothpastes, mouth washes, and chewing gums.Type: ApplicationFiled: June 3, 2014Publication date: May 12, 2016Inventors: Suresh CHAWRAI, Sudhanand PRASAD, Kirti BAJAJ
-
Publication number: 20160058775Abstract: The present disclosure provides compositions comprising antimicrobial agent and excipient, wherein the composition is devoid of fatty acids or their esters having more than 10 carbons. The present disclosure also provides compositions comprising antimicrobial agent and excipient, wherein the composition has at least one fatty acid/ester with carbon chain smaller than C11, and wherein the composition is devoid of fatty acids or their esters having more than 10 carbons. In an embodiment of the present disclosure, the compositions are a nanocomposite wherein particle size of at least one component is in nanoscale range. Further, the present disclosure also relates to formulating said compositions in a manner wherein, particle size or globule size of the formulation is in nanoscale range. The present disclosure also provides process for obtaining said compositions or formulations along with methods for treating microbial infections by using the compositions or the formulations of the present disclosure.Type: ApplicationFiled: April 12, 2014Publication date: March 3, 2016Inventors: Sudhanand PRASAD, Sumana GHOSH, Suresh Rameshlal CHAWRAI, Nilu JAIN
-
Publication number: 20140364440Abstract: The present invention is directed to anti-fungal compositions comprising an anti-fungal agent, an oil and excipients or additives. The compositions of the present invention are devoid of C-11 or greater fatty acids/esters.Type: ApplicationFiled: December 20, 2012Publication date: December 11, 2014Inventors: Abhijit S. Bapat, Sudhanand Prasad, Nilu Jain, Nidhi Arora, Gauthami Mahesh, Mallika Mishra, Sumana Ghosh, Suresh Chawrai, Debabrata Mandal
-
Publication number: 20140364595Abstract: The invention provides conjugate-based antifungal or antibacterial prodrugs formed by coupling at least one anti-fungal agent or antibacterial agent with at least one linker and/or carrier. The prodrugs are of formula: (i) (AFA)m-X-(L)n; (ii) [(AFA)m?-X]p-L; (iii) AFA-[X-(L)n?]q; or (iv) (AFA)m?-X, wherein: AFA is an antifungal agent or an antibacterial agent; L is a carrier; X is a linker; m ranges from 1 to 10; n ranges from 2 to 10; m? is 1 to 10; p is 1 to 10; n? is 1 to 10; and q is 1 to 10, provided that q? and n are not both 1; and m? is 1 to 10. The invention also provides nanoparticles comprising the conjugate-based prodrugs. Additionally, the invention also provides non-conjugated antifungal and antibacterial agents in the form of nanoparticles.Type: ApplicationFiled: June 22, 2012Publication date: December 11, 2014Applicant: VYOME BIOSCIENCESInventors: Abhijit S. Bapat, Gauthami Mahesh, Rajesh S. Gokhale, Sayali S. Shah, Shiladitya Sengupta, Sudhanand Prasad, Sumana Ghosh, Suresh R. Chawrai, Nidhi Arora, D. Sreedhar Reddy, Malika Mishra, Kirti Bajaj
-
Publication number: 20110269680Abstract: The present invention relates to a peptide selected from a group comprising GLP-1 analogs, its truncated forms, or pharmaceutically acceptable salts and derivatives thereof. The present invention further relates to a peptide selected from a group comprising GLP-1 analogs, its truncated forms, or pharmaceutically acceptable salts and derivatives thereof, wherein one or more aminoacids are substituted with a non-coded aminoacid.Type: ApplicationFiled: December 24, 2009Publication date: November 3, 2011Applicant: PANACEA BIOTEC LIMITEDInventors: Rajesh Jain, Virender Kumar Vinayak, Sudhanand Prasad
-
Patent number: 7781398Abstract: The present invention relates to a combination of peptides that may be used for treatment of cancer. The peptide combination competes for the binding of specific neuropeptides at the plasma membrane and thereby alters the levels of key intracellular molecules implicated in cell proliferation, resulting in a broad spectrum of anticancer activity. The invention also relates to pharmaceutical compositions containing a combination of such peptide analogs.Type: GrantFiled: December 21, 2006Date of Patent: August 24, 2010Assignee: Dabur Pharma Ltd.Inventors: Rama Mukherjee, Anand C. Burman, Anu T. Singh, Manu Jaggi, Sudhanand Prasad, Sarjana Dutt
-
Publication number: 20070093422Abstract: The present invention relates to a combination of peptides that may be used for treatment of cancer. The peptide combination competes for the binding of specific neuropeptides at the plasma membrane and thereby alters the levels of key intracellular molecules implicated in cell proliferation, resulting in a broad spectrum of anticancer activity. The invention also relates to pharmaceutical compositions containing a combination of such peptide analogs.Type: ApplicationFiled: December 21, 2006Publication date: April 26, 2007Applicant: DABUR RESEARCH FOUNDATIONInventors: Rama Mukherjee, Anand Burman, Anu Singh, Manu Jaggi, Sudhanand Prasad, Sarjana Dutt
-
Patent number: 7173006Abstract: The present invention relates to a combination of peptides that may be used for treatment of cancer. The peptide combination competes for the binding of specific neuropeptides at the plasma membrane and thereby alters the levels of key intracellular molecules implicated in cell proliferation, resulting in a broad spectrum of anticancer activity. The invention also relates to pharmaceutical compositions containing a combination of such peptide analogs.Type: GrantFiled: December 23, 2002Date of Patent: February 6, 2007Assignee: Dabur Research FoundationInventors: Rama Mukherjee, Anand C. Burman, Anu T. Singh, Manu Jaggi, Sudhanand Prasad, Sarjana Dutt
-
Patent number: 7094755Abstract: The present invention encompasses novel analogs of vasoactive intestinal peptide (VIP), containing substitutions at appropriately selected amino acids. The invention particularly relates to the design and synthesis of novel biologically active VIP analogs containing ?, ?-dialkylated amino acids in a site-specific manner. Specifically, the invention relates to the synthesis of VIP peptide derivatives, which bind selectively to VIP receptors on target cells. The invention encompasses methods for the generation of these peptides, compositions containing the peptides and the pharmacological applications of these peptides especially in the treatment and prevention of cancer.Type: GrantFiled: September 25, 2002Date of Patent: August 22, 2006Assignee: Dabur Research FoundationInventors: Anand C. Burman, Sudhanand Prasad, Rama Mukherjee, Anu T. Singh, Archna Mathur, Neena Gupta
-
Patent number: 7060678Abstract: Anticancer peptides which incorporate furanoid sugar amino acids and compositions made using these peptides are described. Methods for synthesis of the peptides and for preparing the furanoid sugar amino acids are disclosed. The peptides and compositions made using the peptides have pharmacological applications of these peptides especially in the treatment and prevention of cancer and tumors.Type: GrantFiled: August 8, 2003Date of Patent: June 13, 2006Assignee: Dabur Research FoundationInventors: Sudhanand Prasad, Tushar Kanti Chakraborty, Archna Mathur, Manu Jaggi, Ajit Chand Kunwar, Rama Mukherjee, Anand C. Burman
-
Patent number: 6989371Abstract: The present invention encompasses novel peptides that are antagonists to bombesin and bombesin like peptides and are useful in the treatment of cancer. The invention particularly relates to the design and synthesis of the novel peptides incorporating ?,?-amino acids in a site specific manner. The invention encompasses methods for the generation of these peptides, compositions containing the peptides and the pharmacological applications of these peptides especially in the treatment and prevention of cancer.Type: GrantFiled: July 31, 2000Date of Patent: January 24, 2006Assignee: Dabur Research FoundationInventors: Anand C. Burman, Sudhanand Prasad, Rama Mukherjee, Manu Jaggi, Anu T. Singh, Archna Mathur
-
Patent number: 6949513Abstract: A polypeptide of the formula (I), Pa-L-Pb-L-Pc-L-Pd.Type: GrantFiled: June 28, 2002Date of Patent: September 27, 2005Assignee: Dabur Research FoundationInventors: Sudhanand Prasad, Rama Mukherjee, Anand C. Burman, Archna Mathur, Rajan Sharma, Manu Jaggi
-
Publication number: 20050032707Abstract: Anticancer peptides which incorporate furanoid sugar amino acids and compositions made using these peptides are described. Methods for synthesis of the peptides and for preparing the furanoid sugar amino acids are disclosed. The peptides and compositions made using the peptides have pharmacological applications of these peptides especially in the treatment and prevention of cancer and tumors.Type: ApplicationFiled: August 8, 2003Publication date: February 10, 2005Inventors: Sudhanand Prasad, Tushar Chakraborty, Archna Mathur, Manu Jaggi, Ajit Kunwar, Rama Mukherjee, Anand Burman